Related Experiment Video

Updated: Jul 6, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

[Expression and significanc of ERbeta and HER2 in breast cancer]

Shun-E Yang1, Xun Li

  • 1yangshune@medmail.com.cn

Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|April 10, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Experiment Videos

Last Updated: Jul 6, 2026

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
11:12

Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material

Published on: August 1, 2018

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
08:28

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

Articles linked to this work by shared authors, journal, and citation graph.

Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective study.

Frontiers in oncology·2023

Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in China.

Annals of translational medicine·2022

Comparisons of Treatment for HER2-Positive Breast Cancer between Chinese and International Practice: A Nationwide Multicenter Epidemiological Study from China.

Journal of oncology·2021

Profile and outcome of receptor conversion in breast cancer metastases: a nation-wide multicenter epidemiological study.

International journal of cancer·2020

Peptide-Mediated Immobilization on Magnetoferritin for Enzyme Recycling.

Nanomaterials (Basel, Switzerland)·2019

Enterochromaffin cell hyperplasia in the gut: Factors, mechanism and therapeutic clues.

Life sciences·2019

[Research progress on interval cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[A single-center retrospective study on the efficacy and safety of spatially fractionated radiation therapy in patients with advanced/recurrent metastatic malignant tumors].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Clinicopathological, molecular characteristics and prognostic analysis of non-small cell lung cancer with HER-2 genetic variations].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Preliminary exploration of BBOX1-AS1 as a potential biomarker involved in the regulation of tumor cell proliferation in non-small cell lung cancer].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Analysis and prediction study on the burden of malignant neoplasms of bone and articular cartilage in East Asian countries from 1990 to 2023].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026

[Current research status of the intratumoral microbiome and evolution of detection technologies].

Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us